BlackRock Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$2.41M Sell
3,000
-15
-0.5% -$12K ﹤0.01% 2099
2016
Q3
$2.55M Buy
3,015
+8
+0.3% +$6.76K ﹤0.01% 1955
2016
Q2
$2.48M Buy
3,007
+316
+12% +$260K ﹤0.01% 1939
2016
Q1
$3M Buy
2,691
+126
+5% +$140K ﹤0.01% 1723
2015
Q4
$3.2M Buy
2,565
+13
+0.5% +$16.2K ﹤0.01% 1724
2015
Q3
$3.45M Sell
2,552
-36
-1% -$48.7K ﹤0.01% 1643
2015
Q2
$4.66M Buy
2,588
+823
+47% +$1.48M 0.01% 1555
2015
Q1
$2.85M Buy
1,765
+206
+13% +$333K ﹤0.01% 1786
2014
Q4
$1.19M Sell
1,559
-29
-2% -$22.1K ﹤0.01% 2424
2014
Q3
$629K Buy
1,588
+8
+0.5% +$3.17K ﹤0.01% 2826
2014
Q2
$955K Buy
1,580
+92
+6% +$55.6K ﹤0.01% 2630
2014
Q1
$1.02M Buy
1,488
+30
+2% +$20.6K ﹤0.01% 2476
2013
Q4
$949K Buy
1,458
+185
+15% +$120K ﹤0.01% 2530
2013
Q3
$753K Buy
1,273
+60
+5% +$35.5K ﹤0.01% 2636
2013
Q2
$384K Buy
+1,213
New +$384K ﹤0.01% 2979